Mono Pharmacare Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Mono Pharmacare

CMP

40.80

+1.80 (4.62%)

  • DRHP
₹28

Offer Price

₹ 14.84 Cr

Issue Size

₹ 1,12,000

Min Investment

4,000

Lot size

Time Line

  • 28
    Aug 2023
    Open
  • 30
    Aug 2023
    Close
  • 04
    Sep 2023
    Finalisation of Basis of Allotment
  • 05
    Sep 2023
    Initiation of Refunds
  • 06
    Sep 2023
    Transfer of Shares to Demat Account
  • 07
    Sep 2023
    Listing Date

Objects of the Offer

  • Increasing operational efficiency.

  • Broaden and deepen presence in existing product portfolio.

  • Enhance customer base by entering new geographies.

  • To increase brand visibility.

  • Customer satisfaction.

Products & Services

  • The Company is engaged in the business of marketing of pharmaceutical products and also, it is distributors of various pharmaceutical companies.

Strengths

  • Experienced promoters and management team with industry knowledge and an established track record.

  • Asset-light business model and competitive products.

  • Scalable Business Model.

  • Wide and diverse range of product offerings.

Risks

  • The company relies on third parties for manufacturing products of the Company.

  • The company are yet to receive No Objection Certificate ("NoC") from banks, and its yet to create charge with Registrar of Companies ("RoC") in respect of those loan facilities availed.

  • In past, the company has undertaken and may continue to undertake strategic investments, acquisitions and mergers in the future, which may be difficult to integrate and manage. Its future success depends on its ability to achieve and manage growth, whether through internal growth or strategic acquisitions.

  • The company is involved in high volume - low margin business. Any disruption in its turnover or failure to regularly grow the same may have a material adverse effect on its business, results of operations and financial condition.

  • The company top ten customers contribute majority of its revenues from operations. Any loss of business from one or more of them may adversely affect its revenues and profitability.

Company Promoters

Promoters Holding

Issue For IPO
81.02%
Pre Holding

81.02%

Post Holding

-

Top Promoters Holding

Financials

All values in Cr

Mar-2023 Mar-2023 Mar-2023 3-Yr trend
Revenue 0.94 (-) 33.09 (-) 9.01 (-)
Gross Profit 0.94 (-) 33.09 (-) 9.01 (-)
Net Income 0.94 (-) 33.09 (-) 9.01 (-)
Assets 0.94 (-) 33.09 (-) 9.01 (-)
Liabilities 0.94 (-) 33.09 (-) 9.01 (-)

Peers

Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Mono Pharmacare Ltd 33.09 0.94 53.62 39.93 9.01 1.53 11.06 6.83 0.74
Chandra Bhagat Pharma Ltd 119.67 0.91 60.58 60.58 3.29 1.20 36.42 1.49 0.69

Book Running Managers

  • Unistone Capital Pvt Ltd

Registrar & Transfer Agent

Bigshare Services Pvt Ltd

Office No 56-2,
Pinnacle Busine.Park,
Mahakali Caves Road - Mumbai - 400093
Phone : 91-22-62638200 Fax: 91-22-63638299

Company Contact Information

1A Krinkal Apartment opp,
Mahalaxmi Temple Paldi,
Ahmedabad - 380007
Phone : +91-99780 41356 Email : cs@monopharmacareltd.com www.monopharmacareltd.com

Offer Related Information

Initial public issue of 53,00,000 equity shares of face value of Rs. 10 each ("Equity Shares") of Mono Pharmacare Limited ("Company") for cash at a price of Rs. 28 per equity share (including a share premium of Rs. 18 per equity share) ("Issue Price") aggregating up to Rs. 14.84 crores of which up to 2,76,000 equity shares of face value of Rs. 10 each for cash at a price of Rs. 28 per equity share including a share premium of 18 per equity share aggregating to Rs. 0.77 crores will be reserved... More

Take your research to the next level.
Login now to unlock Exclusive Features!

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: